Acute Tumor Lysis Syndrome on the First Day of Chemotherapy in a Patient with Relapsed Non-Hodgkin's Lymphoma.

Accession number;00A0534636
Title;Acute Tumor Lysis Syndrome on the First Day of Chemotherapy in a Patient with Relapsed Non-Hodgkin's Lymphoma.
Author; IKENO TSUNEHISA (National Sanatorium Kitagata Hospital) HIDAKA TAKUMA (National Sanatorium Kitagata Hospital) TSUBOKURA HIFUMI (National Sanatorium Kitagata Hospital) FUJITA YOICHI (National Sanatorium Kitagata Hospital) HAMADA AKIRA (National Sanatorium Kitagata Hospital) OZAWA SHINJI (National Sanatorium Kitagata Hospital) KITAO TAKESHI (National Sanatorium Kitagata Hospital) HASHIMOTO ISAO (National Sanatorium Kitagata Hospital)
Journal Title;Japanese Journal of National Medical Services
Journal Code:F0707A
ISSN:0021-1699
VOL.54;NO.4;PAGE.179-182(2000)
Figure&Table&Reference;FIG.5, TBL.2, REF.6
Pub. Country;Japan
Language;Japanese
Abstract;Acute tumor lysis syndrome consists of combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia, and hypocalcemia, occurrs generally in patient with a high LDH level or renal insufficiency. We reported a 77 year old female with relapsed Non-Hodgkin's lyrnphoma who developed acute tumor lysis syndrome. Before chemotherapy, multiple lymph nodes were swollew on physical examination and atypical cells were present in peripheral blood. Laboratory data showed normal renal function and LDH level. After starting chemotherapy (ABEP therapy), urine volume was decreased. twenty-four hours later, ECG showed tall T-wave and laboratory data showed hyperkalemia (K8.1mEq/l), hyperuricemia (UA18.9mg/dl) and renal dysfunction (Cr1.9mg/dl). Acute tumor lysis syndrome is seen less frequently after routine use of allopurinol and hydration. All patients receiving chemotherapy should be closely monitored. (author abst.)